You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 161 No. 17, September 24, 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Comments, Opinions, and Brief Case Reports
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (4)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in this journal
 Topic Collections
 •Coagulation Disorders
 •Thrombolysis
 •Venous Thromboembolism
 •Alert me on articles by topic

Does Anticoagulant Treatment Reduce the Mortality of Acute Pulmonary Embolism?

Arch Intern Med. 2001;161:2148.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

A number of controlled trials have demonstrated that anticoagulant treatment of pulmonary embolism (PE) will reduce the recurrence rate of venous thromboembolism. Pooling symptomatic and asymptomatic cases is usually required to achieve statistical significance. However, recent trials have not demonstrated a reduction in mortality rates when anticoagulant treatment is compared with placebo or when widely varying durations, intensities, and types of anticoagulant therapy are compared. Many of the numerous trials that have failed to demonstrate a reduction in fatal PE have involved large numbers of subjects, suggesting that if such an effect exists it is very small.

To my knowledge, the only placebo-controlled trial that suggested a reduction in PE mortality was a 1960 study by Barritt and Jordan,1 who observed that 5 of 19 patients died of PE in the untreated group, compared with none of 16 in the treated group. Using a continuity-adjusted {chi}2 test yields a P value . . . [Full Text of this Article]


RELATED LETTERS

Does Anticoagulant Therapy Reduce Mortality of Acute Pulmonary Embolism?
Stuart J. Padove and James E. Dalen
Arch Intern Med. 2002;162(6):720.
EXTRACT | FULL TEXT  

Association of Diphenhydramine Use With Adverse Effects in Hospitalized Older Patients: Possible Confounders
John R. Meuleman, Joseph V. Agostini, and Sharon K. Inouye
Arch Intern Med. 2002;162(6):720-721.
EXTRACT | FULL TEXT  

Anticoagulation in Acute Pulmonary Embolism
James Kelly, Anthony Rudd, Beverley J. Hunt, and Roger R. Lewis
Arch Intern Med. 2002;162(10):1195.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cryptogenic organising pneumonia.
Cordier
Eur Respir J 2006;28:422-446.
ABSTRACT | FULL TEXT  

Anticoagulation in Acute Pulmonary Embolism
Kelly et al.
Arch Intern Med 2002;162:1195-1195.
FULL TEXT  

Does Anticoagulant Therapy Reduce Mortality of Acute Pulmonary Embolism?
Padove and Dalen
Arch Intern Med 2002;162:720-720.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.